You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Medscape Onsite: Prostate and Bladder Cancer Updates

  • Authors: Petros Grivas, MD, PhD; Alicia K. Morgans, MD, MPH
  • CME / ABIM MOC Released: 6/23/2023
  • Valid for credit through: 6/23/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, urologists, and radiologists.

The goal of this activity is for learners to be better able to manage bladder and prostate cancer and provide recommendations for integrating emerging clinical trial data into clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key clinical trial data for the treatment of prostate and bladder cancer reported at a major oncology medical meeting
    • Incorporation of emerging data from a major oncology medical meeting into the treatment paradigms for patients with prostate or bladder cancer
  • Demonstrate greater confidence in their ability to
    • Stay abreast of evolving areas of interest for therapies from a major oncology medical meeting


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Petros Grivas, MD, PhD

    Professor, Division of Medical Oncology
    University of Washington School of Medicine
    Clinical Director, Genitourinary Cancers Program
    UW Medicine
    Professor, Clinical Research Division
    Fred Hutchinson Cancer Center
    Seattle, Washington

    Disclosures

    Petros Grivas, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: 4D Pharma PLC; Aadi Bioscience; Astellas Pharma, Inc.; AstraZeneca; Boston Gene; Bristol Myers Squibb Company; CG Oncology Inc.; Dyania Health; EMD Serono, Inc.; Exelixis, Inc.; Fresenius Kabi; Genentech/ Roche; Gilead Sciences, Inc.; Guardant Health, Inc.; Infinity Pharmaceuticals; Janssen Biotech, Inc.; Lucence Health; Merck Sharp & Dohme GmbH; Mirati Therapeutics; Pfizer, Inc.; PureTech Ventures; QED Therapeutics; Regeneron Pharmaceuticals, Inc.; Seagen, Inc. Inc.; Silverback Therapeutics; UroGen
    Research funding from: Bavarian Nordic; Bristol Myers Squibb Company; Clovis Oncology; Debiopharm; EMD Serono, Inc.; G1 Therapeutics; Gilead Sciences, Inc.; GlaxoSmithKline; Merck Sharp & Dohme GmbH; Mirati Therapeutics; Pfizer, Inc.; QED Therapeutics

  • Alicia K. Morgans, MD, MPH

    Associate Professor of Medicine
    Harvard Medical School
    Genitourinary Medical Oncologist
    Medical Director of the Survivorship Program
    Dana-Farber Cancer Institute
    Boston, Massachusetts

    Disclosures

    Alicia K. Morgans, MD, MPH, has the following relevant financial relationships:
    Consultant or advisor for: Advanced Accelerator Applications; Astellas Pharma, Inc.; AstraZeneca; Bayer; Janssen Biotech, Inc.; Exelixis, Inc.; Lantheus Medical Imaging; Myovant Sciences Ltd.; Myriad Genetics; Novartis; Pfizer, Inc.; Sanofi; Telix
    Research funding from: Astellas Pharma, Inc.; Bayer; Lantheus Medical Imaging; Myovant Sciences Ltd.; Pfizer, Inc.; Sanofi

Editor

  • John Churchwell, MS, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    John Churchwell, MS, PhD, has the following relevant financial relationships:
    Previously employed by Medtronic.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Medscape Onsite: Prostate and Bladder Cancer Updates

Authors: Petros Grivas, MD, PhD; Alicia K. Morgans, MD, MPHFaculty and Disclosures

CME / ABIM MOC Released: 6/23/2023

Valid for credit through: 6/23/2024, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print